
EU antitrust regulators on Thursday fined Barclays, Credit Suisse, HSBC and NatWest 344 million euros ($390 million) for foreign exchange market rigging, reported Reuters.
UBS avoided a 94 million euro fine by alerting the European Commission to the cartel, which was set up via a chatroom known as “Sterling Lads”.
HSBC received the largest fine at 174.3 million euros, followed by Credit Suisse at 83.3 million euros, Barclays at 54.3 million and RBS at 32.5 million.
Barclays, HSBC and RBS – known as NatWest since a rebranding – admitted wrongdoing in return for a reduced penalty. NatWest said the misconduct took place about a decade ago in a single chatroom, involved a former employee and that its culture and controls had since fundamentally changed.
UBS said it had been the first bank to disclose potential misconduct and was pleased the matter was resolved. Some of the world’s biggest banks have been fined more than $11 billion collectively by U.S. and European regulators since allegations first surfaced around 2013 that dealers were rigging the world’s largest financial market. Dozens of traders were suspended or fired.
The latest investigation focused on foreign exchange (forex) spot trading of G10 currencies, the most liquid and traded currencies in the world, which include the US dollar, pound and euro.
Traders exchanged sensitive information and trading plans and sometimes coordinated strategies through the online chatroom, the Commission said.
“Today we complete our sixth cartel investigation in the financial sector since 2013 and conclude the third leg of our investigation into the foreign exchange spot trading market,” EU antitrust chief Margrethe Vestager said in a statement.
She said the collusive behaviour of the five banks undermined the integrity of the financial sector at the expense of the European economy and consumers.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas